ISCHEMIC SKIN NECROSIS DUE TO TERLIPRESSIN USE IN A PATIENT WITH HEPATORENAL SYNDROME: A CASE REPORT

Clinical characteristics and treatment of terlipressin‐induced ischemic skin necrosis: A synthesis of 35 literature reported cases

(2022) Yulu Zhou et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance

(2022) Andrew S. Allegretti et al.   LIVER INTERNATIONAL

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome

(2021) Florence Wong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome

(2021) Scott W. Biggins et al.   HEPATOLOGY

The History of Wound Healing

(2020) Tiffany Brocke et al.   SURGICAL CLINICS OF NORTH AMERICA

Terlipressin has stood the test of time: Clinical Overview in 2020 and Future Perspectives.

(2020) Anand V. Kulkarni et al.   LIVER INTERNATIONAL

Ischemic Skin Necrosis in Hepatorenal Syndrome Patient Secondary to Terlipressin

(2019) Raheel Ahmed et al.   JCPSP-Journal of the College of Physicians and Surgeons Pakistan

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

(2018) Paolo Angeli et al.   JOURNAL OF HEPATOLOGY

Terlipressin in the treatment of hepatorenal syndrome

(2018) Haiqing Wang et al.   MEDICINE

Prevalence of chronic wounds in the general population: systematic review and meta-analysis of observational studies

(2018) Laura Martinengo et al.   ANNALS OF EPIDEMIOLOGY

Management of ascites and hepatorenal syndrome

(2017) Salvatore Piano et al.   Hepatology International

Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis

(2017) Ji-Na Zheng et al.   Expert Review of Gastroenterology & Hepatology

Abnormal laboratory results: Therapeutic drug monitoring: which drugs, why, when and how to do it

(2016) RA Ghiculesco   Australian Prescriber

Ischemic skin necrosis following terlipressin therapy: Report of two cases and review of the literature

(2016) Turker TASLIYURT et al.   Turkish Journal of Gastroenterology

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis

(2013) SharanabasayyaswamyB Hiremath et al.   INDIAN JOURNAL OF PHARMACOLOGY

Terlipressin: An Asset for Hepatologists!

(2011) S.K. Sarin et al.   HEPATOLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Cutaneous Necrosis Secondary to Terlipressin Therapy

(2009) C Posada et al.   ACTA DERMATO-VENEREOLOGICA

Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome

(2009) Lise L. Gluud et al.   HEPATOLOGY

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis

(2009) Yoshiyuki Narahara et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome

(2008) Aleksander Krag et al.   ADVANCES IN THERAPY

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin for Type 1 Hepatorenal Syndrome

(2008) Arun J. Sanyal et al.   GASTROENTEROLOGY